Patients with symptomatic left bundle branch block (LBBB) may have myocardial ischaemia due to both coronary artery disease and/or cardiomyopathy (microcirculatory abnormalities) and may have concomitant left ventricular (LV) dysfunction. We aimed to assess the feasibility and prognostic value of contemporary stress echocardiography (SE), which can uncover both pathophysiologies in LBBB patients in routine clinical practice, and also aimed to assess the additive value of contrast SE. 
Introduction
Left bundle branch block (LBBB) is related to unfavourable cardiac outcomes and is commonly associated with coronary artery disease (CAD) and/or underlying cardiomyopathy. 1, 2 Thus, patients with LBBB and symptoms suggestive of angina may have myocardial ischaemia both due to CAD and/or due to underlying cardiomyopathy (microcirculatory abnormalities). 3, 4 Hence, it may be inferred that the prognosis in patients with LBBB is determined by the combination of left ventricular (LV) function and myocardial ischaemia. However nuclear imaging, particularly the widely used single-photonemission-computerized tomography (SPECT), due to low spatial resolution may give rise to perfusion defects because of partial volume effects rather than due to myocardial ischaemia. 3 With the advent of harmonic imaging and ultrasound contrast agents and therefore better ability to assess wall thickening (WT), reduction of which is the hallmark of myocardial ischaemia, stress echocardiography (SE) now has the ability to determine myocardial ischaemia accurately. 5 This compounded with improved assessment of LV function may enhance the ability of SE to determine outcome in symptomatic patients with LBBB. The role of SE in the prognostication of patients with LBBB has been studied before, both during exercise and pharmacological testing. Patients with LBBB and abnormal SE have increased all-cause mortality, cardiac death, and major cardiac events. 6, 7 However the feasibility of SE and the ability of SE for the prediction of outcome in day-to-day routine clinical practice, where SE is performed by multiple operators and in the era of ultrasound contrast agents, have not been reported. In this report, we sought to determine in the real world setting the feasibility and the ability of SE to predict outcome and furthermore to assess the impact of ultrasound contrast on prognostication in symptomatic patients with LBBB referred for SE.
Methods
Approval for this project was granted by the Research & Development (R&D) department of the Northwest London Hospitals NHS Trust.
Of a total of 3747 patients who underwent SE in our institution between January 2009 and December 2014, 190 patients had LBBB. Indications for SE included chest pain, shortness of breath, collapse, palpitations, and incidental finding of LBBB on electrocardiography (ECG). ECG criteria for LBBB was a QRS complex 120 ms, with predominantly upright complexes and slurred R waves in leads I, V5, V6 and QS or rS morphology in V1. 8 Three patients had stress-induced LBBB and were included in our study population as these patients are also likely to have underlying cardiomyopathy. 9 Likewise patients with permanent pacemaker and LBBB morphology on the ECG were included as pacing may precipitate cardiomyopathy. 10 In case of repeated studies the first one was selected. The pre-test probability for significant CAD was calculated for the outpatients with no established history of CAD (n ¼ 105) with the use of the Pryor score, whereas the risk for cardiovascular (CV) events in the inpatient population (n ¼ 61) was calculated with the HEART score.
Test protocols
When there was no WT abnormality and patients could exercise, exercise SE was performed. Patients were exercised with treadmill according to Bruce protocol. The echocardiographic images were obtained at rest and immediately post-exercise within 90 s. When the patient could not exercise and no WT abnormality was present at rest, a three-stage protocol was followed and dobutamine was infused at 10 mg increments and up to 40 mg/kg/min. Images were acquired at rest, intermediate (10% increase in heart rate), and peak stage when at least 85% of target heart rate (THR) was achieved. When WT abnormality was present in 3 segments a four-stage protocol was followed in order to assess for biphasic response. Dobutamine was then infused at 5 mg/kg/min and was increased every 5 min by 5 mg/kg/min and up to 20 mg/kg/min; thereafter if tolerated well by 10 mg/kg/min increments every 3 min and up to 40 mg/kg/min. Images were then acquired at rest, low (between 7th and 10th minutes), intermediate (between 12th and 15th minutes), and peak stage. In order to achieve 85% of THR handgrip or intravenous atropine (up to 1.2 mg) was used.
Apical 4-, 2-, and 3-chamber images and parasternal long-axis and shortaxis views were obtained sequentially (iE33; Philips Medical Systems, Eindhoven, The Netherlands). In patients in whom the endocardial borders of 2 contiguous segments were not clearly visualized, ultrasound contrast was utilized as per international recommendations. 11 Sonovue contrast (Bracco Diagnostics, Milan, Italy) was given by slow intravenous bolus injections (0.2-0.4 mL each time) and flushed with 2 mL of 0.9% saline. Imaging with contrast-specific low mechanical index (0.1) mode was used for the assessment of WT. Rest and stress images were displayed side by side for ease of comparison and interpretation. All scans were databased and reported on Medcon Telemedicine Technology (NJ, USA). All patients had stopped negatively chronotropic medications for 48 h before the test.
SE interpretation
The images obtained at the different stages were placed side by side for comparison in a quad-screen mode. Systolic WT and not motion was assessed, as the latter would be always abnormal due to the LBBB. For more accurate interpretation every sequence was played normally and in slow speed-frame by frame to capture systolic WT of the septum and apex which usually occurs briefly during systole and also to capture the occurrence of late systolic WT in posterior-lateral walls. 12 In cases where interpretation continued to be challenging, maximum wall thickness during systole was measured and >40% thickening was considered normal. 13 WT was scored using the 16- 
Outcomes
The outcomes assessed were spontaneous events, i.e. all-cause mortality, CV mortality, and acute myocardial infarction (AMI). Coronary revascularization was also recorded but not considered as an outcome measure. The hospital electronic database and the national mortality database were searched to check occurrence and date of death, AMI, and revascularization. Patients were also contacted by phone when required in order to identify events (AMI or revascularization) performed in different hospitals. AMI was defined as admission to hospital with chest discomfort and elevated cardiac troponin with or without ischaemic electrocardiographic changes. Only Type I AMIs were included in the analysis to avoid variance in the diagnosis of AMIs in the study population.
Where coronary angiography (CA) was performed within 3 months of the SE, the burden of CAD was documented. A normal CA was defined as <50% stenosis in any of the three major coronary arteries by visual assessment. outcome. Logistic regression analysis was used to identify predictors of pre-specified variables. The receiver operating characteristic curve was used [with area under the curve (AUC) reported] to identify the best cutoff value of continuous variables for prediction of outcome. For all tests, a P < 0.05 was considered to be statistically significant. Hazard ratios with 95% confidence intervals were estimated. Statistical analysis was performed with SPSS version 22.0 (SPSS Inc., Chicago, IL, USA).
Statistical analysis

Results
Baseline characteristics
The mean patient age (n ¼ 190) was 70.5 6 11.3 years and mean baseline LVEF was 50.1 6 9.8%. LV systolic dysfunction (LVEF 50%) was present in 74 (38.9%) of patients. In patients without an established history of CAD, the pre-test probability for the outpatients (n ¼ 129, 67.9%) was 52 6 31% (intermediate risk), whereas the HEART score for the inpatients (n ¼ 61, 32.1%) was 4. 
Feasibility of SE
SE was considered conclusive in 176 (92.6%) patients. Only 7 of the 14 inconclusive tests were due to interpretation difficulties (3.7%). Thus, image interpretation was feasible in 183 (96.3%) patients. Other causes of inconclusive tests included presence of arrhythmia at rest, development of arrhythmias during peak stress, and inability to achieve 85% of THR. Table 1 summarizes patient details of these 176 patients who were subsequently followed-up.
Outcomes
During a follow-up period of 35.4 6 20.2 months there were 41 (23.3%) events [32 (18%) deaths of which 13 (7.4%) were CV, and 9 (5%) AMIs], giving rise to 18 (10.2%) patients with first CV event (mortality/AMI). Thus, annual mortality and CV event rates in this group of patients were high (6.2% and 3.5%, respectively). There were 17 patients revascularized over the follow-up period, of which 15 had percutaneous coronary intervention (PCI) and three had coronary artery bypass grafting (one patient had both PCI and coronary artery bypass grafting).
Inducible ischaemia was present in 25 (14.2%) patients. Seventeen of these patients had CA. Of those eight had normal CA (defined as <50% stenosis in any of the three major coronary arteries). Therefore 9 of the 17 SEs with ischaemia demonstrated CAD (53%). Of the eight patients with normal coronaries and myocardial ischaemia two (25%) suffered events during follow-up.
There were 78 patients with myocardial ischaemia and/or LVEF <50% at rest, of which 22 (28.2%-annual mortality rate 9.6%) died compared with 98 patients with no ischaemia and normal LVEF at rest, of which 10 (10.2%-annual mortality rate 3.4%) died (P ¼ 0.002). CV events occurred in 12 (15.4%-annual rate 5.1%) of 78 patients with myocardial ischaemia and/or abnormal LV systolic function compared with 6 (6.1%-annual rate 2%) of 98 patients with no myocardial ischaemia and/or normal LV function (P ¼ 0.022). Figure 1 demonstrates examples of a normal (normal WT despite abnormal wall motion at peak stress) (see supplementary data online, Videos S1 and S2) and an abnormal SE with myocardial ischaemia [reduced WT at stress in the right coronary artery (RCA) territory] (see supplementary data online, Videos S3 and S4) in the apical twochamber view in two patients with LBBB. In the abnormal SE case, CA confirmed the presence of RCA flow-limiting disease (see supple mentary data online, Video S5). Figure 2 shows Kaplan-Meier survival curve for all-cause mortality demonstrating significantly worse outcome in patients with LBBB and abnormal SE (myocardial ischaemia and/or LV dysfunction) vs. normal SE.
Predictors of outcome
Amongst WTSI rest , WTSI interm , and WTSI peak , the latter was the most significant predictor of mortality. Therefore in order to overcome the effects of co-linearity of these three parameters, the most significant parameter, i.e. WTSI peak was selected for all the outcome analysis. WTSI peak represents both baseline WT abnormalities and presence of inducible ischaemia. All-cause mortality was predicted by Contemporary SE in LBBB patients Figure 1 Examples of a normal (normal WT despite abnormal wall motion at peak stress) (A), and an abnormal SE with myocardial ischaemia (reduced WT at stress in the RCA territory) (B), in the apical two-chamber view in two patients with LBBB. In the abnormal SE case, CA confirmed the presence of RCA flow-limiting disease. CA, coronary angiography; LBBB, left bundle branch block; RCA, right coronary artery; SE, stress echocardiography; WT, wall thickening. Table 2) . CV events were predicted by increasing age, CKD, previous IHD, follow-on revascularization, and WTSI peak in the univariable analysis. In the multivariable analysis, CKD (HR ¼ 4.85, 95% CI ¼ 1.74-13.52, P ¼ 0.03) and WTSI peak (HR ¼ 3.96, 95% CI ¼ 1.09-14.28, P ¼ 0.036) were independent predictors of CV events ( Table 3) .
WTSI peak of 1.16 (WTSI 1.16 ) was identified by constructing receiver operating characteristic curve as the optimal cut-off value for prediction of all-cause mortality (AUC 0.57, 95% CI¼ 0.46-0.69) and CV mortality (AUC 0.62, 95% CI ¼ 0.47-0.768). Patients with WTSI peak 1.16 had significantly worse outcome [all-cause mortality (P ¼ 0.02) and CV mortality/myocardial infarction (MI) (P ¼ 0.003)] compared with those with WTSI peak <1.16.
Factors that affect WT assessment
Factors that affect WT assessment in patients with LBBB were evaluated to clarify which such factors in SE improve prediction of prognostically important WTSI peak , which is WTSI 1.16 . Amongst such confounders, i.e. QRS duration, presence of AF, presence of pacemaker, exercise/pharmacological stress, use of contrast, peak heart rate and previous MI, use of contrast (HR ¼ 3.96, 95% CI ¼ 1.25-12.58, P ¼ 0.019) and previous MI (HR ¼ 3.62, 95% CI ¼ 1.58-8.3, P ¼ 0.002) were the two independent predictors of WTSI 1.16 . Interestingly when clinical risk factors, i.e. age, gender, hypertension, smoking, diabetes mellitus, hypercholesterolaemia, and previous revascularization were added in the model, contrast (HR ¼ 3.62, 95% CI ¼ 1.1-11.9, P ¼ 0.034) and previous MI (HR ¼ 4.25, 95% CI ¼ 1.64-11.04, P ¼ 0.003) remained independent predictors of WTSI 1.16 with the addition of gender (HR ¼ 2.64, 95% CI ¼ 1.06-6.58, P ¼ 0.038) and diabetes (HR ¼ 2.38, 95% CI ¼ 1.01-5.57, P ¼ 0.047) ( Table 4) .
Discussion
The real-world observational study where SE was performed by multiple operators, using both exercise and dobutamine stress modalities and where contrast was used in 75% of patients, showed that SE was feasible in >90% of patients with LBBB with image interpretation possible in >95% of such patients. Furthermore, SE provided incremental prognostic information beyond clinical data in these patients referred clinically for SE. SE predicted both all-cause mortality and CV events. An abnormal SE (myocardial ischaemia and/or abnormal LV function at rest) predicted an almost three-fold increase in allcause mortality and 2.5-fold increase in CV events compared with patients with a normal SE. In this high-risk population (elderly with accompanying significant co-morbidity) where the prevalent annual CV event rate was 3.5%, a normal SE portended an excellent CV outcome (annual CV rate: 2%). This negative predictive value of SE (98%/year) for outcome is in keeping with SE studies in the elderly, but this study demonstrated somewhat better outcome than quoted in the literature. 15, 16 However, population differences can be a major confounder. Finally, the study demonstrated that echo-contrast usage in SE improved prediction of prognostically significant SE parameter for both all-cause mortality and CV events. LBBB is often associated with CAD and/or underlying cardiomyopathy. Myocardial ischaemia may thus be precipitated by both CAD and cardiomyopathy. Hence, the above partly accounts for lower value of stress techniques, which primarily detect myocardial ischaemia, for predicting CAD. This is shown in both our study and others. 17 However despite the absence of flow-limiting CAD in patients demonstrating myocardial ischaemia, 25% went on to have events emphasizing the deleterious effects of underlying cardiomyopathy. This is further exemplified by the fact that in this study WTSI during peak stress, which is a combination of the extent and presence of myocardial ischaemia and LV dysfunction, provided independent prognostic information beyond that provided by known clinical variables. Another issue with stress techniques and patients with LBBB is the difficulty in interpreting both wall motion abnormalities, which is assessed by SE and CMR, and perfusion defects assessed by SPECT. Wall motion in the septum and apex is almost always abnormal in patients with LBBB and delayed endocardial inward motion occurs in other parts of the LV. However, WT is almost always normal in all parts of LV in LBBB in the absence of myocardial ischaemia. The assessment of WT is improved in SE when images are enhanced by echo-contrast agents. The dense echoes in LV cavity contrasting with lighter echoes from the myocardium (signal intensity from contrast microbubbles is proportional to blood volume which is larger in LV cavity compared with the myocardium) enhance not only the endocardium but also the epicardium allowing improved assessment of WT. 5 In this study of consecutive patients with LBBB assessed with SE performed by multiple operators and where contrast was used in 75% of patients, feasibility was 93% with interpretable images in 96% of patients. In other studies with LBBB, patients with difficult echo windows were excluded and no other details were provided regarding patients where SE was not feasible. 7, 17 This study further showed that this probable improved assessment of WT with contrast translated to better prediction of outcome. Amongst other confounders of WT assessment in LBBB (QRS duration, presence of AF, presence of pacemaker, exercise/pharmacological stress, peak heart rate, and previous MI), contrast usage independently predicted the presence of prognostically significant WTSI peak . It remained significant even after adjusting for prognostically important clinical factors demonstrating the value of using contrast for the assessment of WT in LBBB during SE. The other most commonly used technique is SPECT. SPECT tends to give rise to high rate of false-positive perfusion defects both at rest and during stress. This is mainly due to partial volume effects as a result of low spatial resolution. Shorter duration of WT in the septum compounded by reduced thickness of the septum in LBBB particularly in patients with LV dysfunction results in reduced radioactive counts compared with walls with normal thickening pattern and thickness. 3 Thus because techniques with higher spatial resolution like myocardial contrast echocardiography and cardiac magnetic resonance imaging are unaffected by the characteristic changes produced by LBBB, false-positive perfusion defects are significantly reduced. Myocardial contrast echocardiography is a good alternative technique to assess patients with LBBB as it provides information of myocardial ischaemia and LV function with a high degree of accuracy while being a bedside technique. 18, 19 Other studies had shown the prognostic value of SE. 7, 17 However, these studies did not address the issue of feasibility and it is not clear whether the data were derived from consecutive patients in routine day-to-day clinical practice.
Clinical implications
Contemporary SE is a highly feasible bedside technique free of ionizing radiation providing clinically useful information in patients with LBBB. In the era of contrast echocardiography WT and LV function can be assessed accurately. With improved image quality provided by contemporary echocardiography (harmonic imaging and contrast usage) and the ability to assess the systolic WT frame by frame, SE remains a viable first line test in patients with LBBB.
Study limitations
This was a single-centre retrospective study. Furthermore a single expert performed the interpretation, which might have introduced observer bias; however the study reflects real world, day-to-day clinical practice, where typically a single physician with special interest in SE will interpret the test. Future randomized controlled studies in patients with LBBB that will specifically address the value of contrast would be of interest.
Conclusion
SE is feasible and provides important prognostic information in patients with symptomatic LBBB. Contrast-enhanced SE improves the prediction of outcome in SE.
Supplementary data
Supplementary data are available at European Heart Journal -Cardiovascular Imaging online.
